A New Prognostic Model for Response in Myelofibrosis Patients Treated with JAK2 Inhibitors: A Study from Three US Academic Centers Kamal, M., Boonstra, P. S., Weber, A. A., Perkins, C., Gowin, K. L., Huong (Marie) Nguyen, Mesa, R., Gotlib, J. R., Talpaz, M. AMER SOC HEMATOLOGY. 2014

View details for Web of Science ID 000349242706220